| George Elvis Dasoveanu, MD | |
|
1199 Prince Ave, Athens, GA 30606 | |
| (706) 475-5076 | |
| (706) 475-6676 |
| Full Name | George Elvis Dasoveanu |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Experience | 33 Years |
| Location | 1199 Prince Ave, Athens, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558310334 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 45764 (Georgia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Amedisys Home Health Of Covington | Covington, GA | Home health agency |
| Piedmont Home Health | Athens, GA | Home health agency |
| Piedmont Athens Regional Medical Center | Athens, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Piedmont Athens Hospitalist Physicians Llc | 6305196411 | 105 |
News Archive
A newly discovered gene known as MCPIP could provide scientists with the key to developing treatments for preventing inflammation that can cause heart disease, University of Central Florida researchers have discovered.
Cheasanee Huette, a 20-year-old college student in Northern California, is worried. Two years ago, knowing she was protected by the Affordable Care Act's guarantees of coverage for preexisting conditions, she decided to find out if she carried the same genetic mutation that eventually killed her mother.
Integra LifeSciences announced today that it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for its Vu aPOD™ Prime anterior lumbar interbody fusion (ALIF) device.
Genprex, Inc. announced today that it has enrolled the first patient in a clinical trial evaluating its lead product candidate Oncoprex in combination with erlotinib (Tarceva) for late-stage lung cancer patients.
› Verified 7 days ago
| Entity Name | Gwinnett Physician Group, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578574661 PECOS PAC ID: 9133211139 Enrollment ID: O20070822001035 |
News Archive
A newly discovered gene known as MCPIP could provide scientists with the key to developing treatments for preventing inflammation that can cause heart disease, University of Central Florida researchers have discovered.
Cheasanee Huette, a 20-year-old college student in Northern California, is worried. Two years ago, knowing she was protected by the Affordable Care Act's guarantees of coverage for preexisting conditions, she decided to find out if she carried the same genetic mutation that eventually killed her mother.
Integra LifeSciences announced today that it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for its Vu aPOD™ Prime anterior lumbar interbody fusion (ALIF) device.
Genprex, Inc. announced today that it has enrolled the first patient in a clinical trial evaluating its lead product candidate Oncoprex in combination with erlotinib (Tarceva) for late-stage lung cancer patients.
› Verified 7 days ago
| Entity Name | Athens Regional Specialty Services, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083939136 PECOS PAC ID: 8325162340 Enrollment ID: O20100827000645 |
News Archive
A newly discovered gene known as MCPIP could provide scientists with the key to developing treatments for preventing inflammation that can cause heart disease, University of Central Florida researchers have discovered.
Cheasanee Huette, a 20-year-old college student in Northern California, is worried. Two years ago, knowing she was protected by the Affordable Care Act's guarantees of coverage for preexisting conditions, she decided to find out if she carried the same genetic mutation that eventually killed her mother.
Integra LifeSciences announced today that it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for its Vu aPOD™ Prime anterior lumbar interbody fusion (ALIF) device.
Genprex, Inc. announced today that it has enrolled the first patient in a clinical trial evaluating its lead product candidate Oncoprex in combination with erlotinib (Tarceva) for late-stage lung cancer patients.
› Verified 7 days ago
| Entity Name | Piedmont Athens Hospitalist Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578079000 PECOS PAC ID: 6305196411 Enrollment ID: O20180911003967 |
News Archive
A newly discovered gene known as MCPIP could provide scientists with the key to developing treatments for preventing inflammation that can cause heart disease, University of Central Florida researchers have discovered.
Cheasanee Huette, a 20-year-old college student in Northern California, is worried. Two years ago, knowing she was protected by the Affordable Care Act's guarantees of coverage for preexisting conditions, she decided to find out if she carried the same genetic mutation that eventually killed her mother.
Integra LifeSciences announced today that it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for its Vu aPOD™ Prime anterior lumbar interbody fusion (ALIF) device.
Genprex, Inc. announced today that it has enrolled the first patient in a clinical trial evaluating its lead product candidate Oncoprex in combination with erlotinib (Tarceva) for late-stage lung cancer patients.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| George Elvis Dasoveanu, MD Po Box 1170, Lawrenceville, GA 30046-1170 Ph: (470) 325-0159 | George Elvis Dasoveanu, MD 1199 Prince Ave, Athens, GA 30606 Ph: (706) 475-5076 |
News Archive
A newly discovered gene known as MCPIP could provide scientists with the key to developing treatments for preventing inflammation that can cause heart disease, University of Central Florida researchers have discovered.
Cheasanee Huette, a 20-year-old college student in Northern California, is worried. Two years ago, knowing she was protected by the Affordable Care Act's guarantees of coverage for preexisting conditions, she decided to find out if she carried the same genetic mutation that eventually killed her mother.
Integra LifeSciences announced today that it has received 510(k) clearance from the United States Food and Drug Administration (FDA) for its Vu aPOD™ Prime anterior lumbar interbody fusion (ALIF) device.
Genprex, Inc. announced today that it has enrolled the first patient in a clinical trial evaluating its lead product candidate Oncoprex in combination with erlotinib (Tarceva) for late-stage lung cancer patients.
› Verified 7 days ago
Adam E Traill, DO Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1230 Baxter Street, Athens, GA 30606 Phone: 706-389-3420 Fax: 706-389-3420 | |
Mr. Basilio Nii Ayitey Addo, M.D Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1270 Prince Ave Ste 201, Athens, GA 30606 Phone: 706-475-7055 | |
John Ransom Morgan, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 1230 Baxter Street, Athens, GA 30606 Phone: 706-389-3420 Fax: 706-389-3411 | |
Kajal Joshi, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 1199 Prince Ave, Athens, GA 30606 Phone: 706-475-5076 | |
Dr. Tiffanni Dior Forbes, M.D. Hospitalist Medicare: Not Enrolled in Medicare Practice Location: 1199 Prince Ave, Athens, GA 30606 Phone: 706-475-4917 | |
Eric Adjei Afari, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1199 Prince Ave, Athens, GA 30606 Phone: 706-475-7869 Fax: 706-475-6676 | |
Andrew Alexander Ke, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1199 Prince Ave, Athens, GA 30606 Phone: 706-475-5076 |